BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Society for Women&#039;s Health Research - ECPv6.16.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://swhr.org
X-WR-CALDESC:Events for Society for Women&#039;s Health Research
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221205T150000
DTEND;TZID=America/New_York:20221205T160000
DTSTAMP:20241206T202359Z
CREATED:20221117T233022Z
LAST-MODIFIED:20241206T202359Z
UID:10000407-1670252400-1670256000@swhr.org
SUMMARY:Closing the Loop for Lupus: A Wellness Toolkit for Women
DESCRIPTION:Lupus is a chronic autoimmune disease characterized by widespread inflammation that often results in damage to the joints\, skin\, brain\, lungs\, kidneys and blood vessels. An estimated 1.5 million Americans have some form of lupus\, and 90% are women between the ages of 15 and 44. Lupus is more prevalent among women of color\, who also develop symptoms at younger ages and have more severe symptoms and complications from the disease.Systemic lupus erythematosus (SLE) is the most common type of lupus\, affecting multiple parts of the body\, and cutaneouslupus erythematosus (CLE) primarily affects theskin. Because the symptoms of lupus mimic other diseases\, a majority of patients are initially misdiagnosed\, and it can take up to 6 years and seeing multiplehealth care specialists before receiving an accurate diagnosis. Women living with lupus have a greater risk for developing other chronic conditions\, such as heart disease and osteoporosis\, or lupus nephritis due to kidney inflammation and damage. Although lupus does not affect fertility\, pregnant women should be aware of potential complications\, such as preeclampsia. \nThere is no cure for lupus\, and the limited treatments available primarily focus on reducing symptom flares\, resulting in insufficiently improved health outcomes.There is a pressing need to address gaps in research and clinical education\, and to develop policy solutions that will eliminate barriers to access for treatments and quality care for women. \nSWHR hosted a series of webinars to share educational information about the impact of lupus on women’s health.The events discussed how to improve health outcomes through recognizing and addressing symptoms\, comorbidities\, treatment options\, and barriers to accessing quality care\, while highlighting the diverse experiences of women living with lupus. \nThe SWHR Closing the Loop for Lupus series includes: \n\nClosing the Loop for Lupus in Women’s Health Care (June 15\, 2022)\nA Fireside Chat (October 17\, 2022)\nA Wellness Toolkit for Women (December 5\, 2022)\n\nFollow the conversation on Twitter at @SWHR and #SWHRtalksLupus. \nThis event is free and open to the public.
URL:https://swhr.org/event/closing-the-loop-for-lupus-a-wellness-toolkit-for-women/
LOCATION:Virtual Event
CATEGORIES:Patient Event,Public Event,Science Event,SWHR Event,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221206T140000
DTEND;TZID=America/New_York:20221206T150000
DTSTAMP:20241122T194935Z
CREATED:20221108T214128Z
LAST-MODIFIED:20241122T194935Z
UID:10000404-1670335200-1670338800@swhr.org
SUMMARY:Addressing Concerns and Considerations Surrounding the Inclusion of Pregnant and Lactating Populations in Research
DESCRIPTION:Pregnant and lactating women have historically been excluded from clinical trials. Federal policies from the 1970s that excluded “women of childbearing age” from research led research to use male participants\, limiting our knowledge base. Although a 1994 report from the Institute of Medicine recommended that pregnant women be presumed to be eligible to participate in clinical studies and that lactating women not be excluded from clinical studies\, concerns remain about including pregnant and lactating populations in research. \nDuring this virtual congressional briefing and national webinar\, panelists reviewed ethical considerations surrounding inclusion of pregnant and lactating women in research\, how to ensure the appropriate inclusion of these populations\, and the current state of this type of inclusion in research\, both within the federal government and the corporate sector. \n  \n\nFollow the conversation on Twitter at @SWHR. \nThis event is free and open to the public. \n  \n\nThis event is part of a series about the inclusion of pregnant and lactating peoples in research. The full series includes: \n\nAddressing Concerns and Considerations Surrounding the Inclusion of Pregnant and Lactating Populations in Research (December 6\, 2022)\nPregnant and Lactating Populations in Research: How Leaving These Populations Out Leaves Them Behind (January 26\, 2023)\nPRGLAC Then and Now: Where We Are and Where We’re Going (February 14\, 2023)
URL:https://swhr.org/event/addressing-concerns-and-considerations-surrounding-inclusion-of-pregnant-and-lactating-populations-in-research/
LOCATION:Virtual Event
CATEGORIES:Policymaker Event,Public Event,SWHR Event,Webinar
END:VEVENT
END:VCALENDAR